U Posted by Laura Moller
\ January 17, 2014

Glucovation’s SugarSenz™ is the first body-worn sensor for glucose, giving users unprecedented insight into their personal metabolic activity. The sensor is painlessly inserted under skin via a simple “place and go” applicator, where it detects glucose levels electrochemically and sends a distilled user-friendly report via smartphone. For the first time ever, anyone can have real-time insight into how their diet and fitness choices impact their metabolism.

The team at Glucovation has completed testing of alpha prototypes and filed IP on their core technology. After their appearance at CES 2014, Glucovation has been featured on Medgadget and DC Rainmaker and garnered interest from tech giants like Garmin, Microsoft, and Samsung.

With $620,000 raised, and 76% funded, Glucovation is moving into beta testing in late Q2/early Q3 of this year. They are looking for additional investors to continue to develop their technology and proprietary software

COMMENTS
No comments yet.

Ready to Start Raising Capital?


GET STARTED 9

the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service funding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.